Stallergenes gains U.S. FDA approval for Oralair allergy drug
(Reuters) - France's Stallergenes said on Tuesday it received the U.S. Food and Drug Administration's green light to sell its immunotherapy pill Orala...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/QY0lVf1tH-Q/story01.htm
No comments:
Post a Comment